Clinical Trial Update: Telcagepant for Prevention of Menstrually Related Migraine in Female Participants With Episodic Migraine (MK-0974-065) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update for telcagepant (MK-0974-065) evaluating prevention of menstrually related migraine in women with episodic migraine; study completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Telcagepant (telcagepant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Migraine | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-10-03